Research News From September 15, 2011
advertisement
- C-Peptide Response and HLA Genotypes in Subjects With Recent-Onset Type 1 Diabetes After Immunotherapy With DiaPep277.
- Effect of rituximab on human in vivo antibody immune responses.
- Advanced Glycation End Products Are Direct Modulators of beta-Cell Function.
- A Longitudinal Study of GAD65 and ICA512 Autoantibodies During the Progression to Type 1 Diabetes in Diabetes Prevention Trial�Type 1 (DPT-1) Participants.